HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kenzoki Plant-Based Line Launches As Kenzo Skin Care Entry

This article was originally published in The Rose Sheet

Executive Summary

Kenzo's premier skin care collection, Kenzoki, is rolling out now as a "serious" aromachology-based line formulated with four plant waters, the LVMH division said. The comprehensive range includes 20 SKUs for the face and body divided into four fragrance families based on each plant water - bamboo leaf, ginger flower, white lotus and rice

You may also be interested in...



FlowerbyKenzo Oriental Spices Up Women’s Fragrance Portfolio

FlowerbyKenzo Oriental for women is bowing this fall as a spicier, more mature version of the original FlowerbyKenzo fragrance, according to the LVMH division

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS011992

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel